Evidence map›Paper›PMID 38352329›Full record

ArticlebioRxiv : the preprint server for biology2024

NeuroTri2-VISDOT: An open-access tool to harness the power of second trimester human single cell data to inform models of Mendelian neurodevelopmental disorders.

Kelly J Clark, Emily E Lubin, Elizabeth M Gonzalez, Annabel K Sangree, Dana E Layo-Carris, Emily L Durham, Rebecca C Ahrens-Nicklas, Tomoki T Nomakuchi, Elizabeth J Bhoj

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Kelly J ClarkBiomedical Graduate School, University of Pennsylvania, Perelman School of Medicine.ORCID 0009-0009-2801-7588
Emily E LubinBiomedical Graduate School, University of Pennsylvania, Perelman School of Medicine.ORCID 0000-0002-6277-1156
Elizabeth M GonzalezBiomedical Graduate School, University of Pennsylvania, Perelman School of Medicine.ORCID 0000-0001-6424-1522
Annabel K SangreeBiomedical Graduate School, University of Pennsylvania, Perelman School of Medicine.ORCID 0000-0002-0298-1856
Dana E Layo-CarrisChildren's Hospital of Philadelphia.ORCID 0000-0001-7009-0652
Emily L DurhamChildren's Hospital of Philadelphia.ORCID 0000-0002-6322-9393
Rebecca C Ahrens-NicklasChildren's Hospital of Philadelphia.ORCID 0000-0001-8243-7123
Tomoki T NomakuchiChildren's Hospital of Philadelphia.ORCID 0000-0001-7300-9311
Elizabeth J BhojChildren's Hospital of Philadelphia.ORCID 0000-0001-5748-3507
Children's Hospital of Philadelphia · US

Funding

MEDICAL GENETICS RESEARCH TRAINING GRANTT32GM008638 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI Rebecca Ganetzky · 1997 to 2026
$8.7M
Postdoctoral Training Program in Genomic MedicineT32HG009495 · NHGRI · UNIVERSITY OF PENNSYLVANIA · PI Katherine L. Nathanson, Bogdan Pasaniuc · 2017 to 2026
$4.2M
De novo mutations in replication-independent histone genes and an unexplored class of rare pediatric mendelian syndromesF30HD112125 · NICHD · UNIVERSITY OF PENNSYLVANIA · PI Emily Elizabeth Lubin · 2024 to 2026
$102k
NHGRI NIH HHS T32 HG009495NICHD NIH HHS F30 HD112125NIGMS NIH HHS T32 GM008638
6 · The paper itself

Abstract

Whole exome and genome sequencing, coupled with refined bioinformatic pipelines, have enabled improved diagnostic yields for individuals with Mendelian conditions and have led to the rapid identification of novel syndromes. For many Mendelian neurodevelopmental disorders (NDDs), there is a lack of pre-existing model systems for mechanistic work. Thus, it is critical for translational researchers to have an accessible phenotype- and genotype-informed approach for model system selection. Single-cell RNA sequencing data can be informative in such an approach, as it can indicate which cell types express a gene of interest at the highest levels across time. For Mendelian NDDs, such data for the developing human brain is especially useful. A valuable single-cell RNA sequencing dataset of the second trimester developing human brain was produced by Bhaduri et al in 2021, but access to these data can be limited by computing power and the learning curve of single-cell data analysis. To reduce these barriers for translational research on Mendelian NDDs, we have built the web-based tool, Neurodevelopment in Trimester 2 - VIsualization of Single cell Data Online Tool (NeuroTri2-VISDOT), for exploring this single-cell dataset, and we have employed it in several different settings to demonstrate its utility for the translational research community.

Identifiers

PMID38352329
PMCPMC10862881
OpenAlexW4391519225

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.